{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:50:58Z","timestamp":1777899058144,"version":"3.51.4"},"reference-count":109,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bprclinrheum.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.berh.2016.04.006","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T05:34:48Z","timestamp":1467956088000},"page":"39-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Connective tissue disease-related interstitial lung disease"],"prefix":"10.1016","volume":"30","author":[{"given":"M. Kristen","family":"Demoruelle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha","family":"Mittoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua J.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.berh.2016.04.006_bib1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1148\/radiology.176.3.2389033","article-title":"Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography","volume":"176","author":"Schurawitzki","year":"1990","journal-title":"Radiology"},{"issue":"2 Pt 1","key":"10.1016\/j.berh.2016.04.006_bib2","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.berh.2016.04.006_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ard.2003.006122","article-title":"Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis","volume":"63","author":"Fathi","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1378\/chest.10-0194","article-title":"Connective tissue disease-associated interstitial lung disease: a call for clarification","volume":"138","author":"Fischer","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.berh.2016.04.006_bib6","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/13993003.00150-2015","article-title":"An official European Respiratory Society\/American Thoracic Society research statement: interstitial pneumonia with autoimmune features","volume":"46","author":"Fischer","year":"2015","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.berh.2016.04.006_bib7","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1136\/annrheumdis-2013-204912","article-title":"Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation","volume":"74","author":"Ytterberg","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2016.04.006_bib8","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38066","article-title":"Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease","volume":"65","author":"Willis","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2016.04.006_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/art.38201","article-title":"Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis","volume":"66","author":"Reynisdottir","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2016.04.006_bib10","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1172\/JCI28756","article-title":"Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis","volume":"116","author":"Rangel-Moreno","year":"2006","journal-title":"J\u00a0Clin Investig"},{"issue":"3","key":"10.1016\/j.berh.2016.04.006_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2217\/ijr.14.23","article-title":"The lung may play a role in the pathogenesis of rheumatoid arthritis","volume":"9","author":"Demoruelle","year":"2014","journal-title":"Int J Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.berh.2016.04.006_bib12","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.rmed.2012.03.006","article-title":"Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease","volume":"106","author":"Fischer","year":"2012","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib13","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.berh.2016.04.006_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10067-009-1128-9","article-title":"Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA","volume":"28","author":"Gizinski","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib15","first-page":"121","article-title":"The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia","volume":"19","author":"Kim","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"12","key":"10.1016\/j.berh.2016.04.006_bib16","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1164\/rccm.2106012","article-title":"Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome","volume":"165","author":"Bouros","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.berh.2016.04.006_bib17","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","article-title":"Polymyositis-dermatomyositis-associated interstitial lung disease","volume":"164","author":"Douglas","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1183\/09031936.03.00026703","article-title":"Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis","volume":"22","author":"Cottin","year":"2003","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1164\/rccm.200403-417OC","article-title":"Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study","volume":"171","author":"Ito","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.berh.2016.04.006_bib20","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.130.5.1489","article-title":"Interstitial lung disease in primary Sjogren syndrome","volume":"130","author":"Parambil","year":"2006","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.berh.2016.04.006_bib21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.200702-220OC","article-title":"Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?","volume":"176","author":"Kinder","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.berh.2016.04.006_bib22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1164\/rccm.200607-912OC","article-title":"Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes","volume":"175","author":"Park","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib23","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.berh.2016.04.006_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1378\/chest.93.1.114","article-title":"Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis","volume":"93","author":"Hakala","year":"1988","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.berh.2016.04.006_bib25","first-page":"770","article-title":"Lung biopsy in rheumatoid arthritis","volume":"131","author":"Yousem","year":"1985","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib26","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/09031936.00019210","article-title":"Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome","volume":"37","author":"Tsuchiya","year":"2011","journal-title":"Eur Respir J."},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib27","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1164\/ajrccm.149.6.8004317","article-title":"Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis","volume":"149","author":"Wells","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.berh.2016.04.006_bib28","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/art.39405","article-title":"Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease","volume":"67","author":"Suliman","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2016.04.006_bib29","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics \u2013 a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib30","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.34344","article-title":"Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?","volume":"64","author":"Demoruelle","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.berh.2016.04.006_bib31","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s10067-015-3095-7","article-title":"Pulmonary hypertension in polymyositis","volume":"34","author":"Wang","year":"2015","journal-title":"Clinical rheumatology."},{"issue":"127","key":"10.1016\/j.berh.2016.04.006_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1183\/09059180.00005512","article-title":"Scleroderma lung disease","volume":"22","author":"Solomon","year":"2013","journal-title":"Eur Respir Rev"},{"issue":"3","key":"10.1016\/j.berh.2016.04.006_bib33","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/ar3037","article-title":"Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study","volume":"12","author":"Pappas","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"19","key":"10.1016\/j.berh.2016.04.006_bib34","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.berh.2016.04.006_bib35","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib36","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.22532","article-title":"Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors","volume":"57","author":"McNearney","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2016.04.006_bib37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1378\/chest.114.3.801","article-title":"African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease","volume":"114","author":"Greidinger","year":"1998","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.berh.2016.04.006_bib38","first-page":"81","article-title":"Relationship between cutaneous and pulmonary involvement in systemic sclerosis","volume":"24","author":"Morelli","year":"1997","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib39","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1378\/chest.07-2444","article-title":"High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease","volume":"134","author":"Goldin","year":"2008","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.berh.2016.04.006_bib40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1055\/s-2007-985609","article-title":"Pulmonary pathology of the rheumatic diseases","volume":"28","author":"Leslie","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.berh.2016.04.006_bib41","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/art.1780370903","article-title":"Severe restrictive lung disease in systemic sclerosis","volume":"37","author":"Steen","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.berh.2016.04.006_bib42","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/art.30467","article-title":"Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group","volume":"63","author":"Khanna","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2016.04.006_bib43","first-page":"1789","article-title":"High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis","volume":"33","author":"Launay","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2016.04.006_bib44","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/thorax.56.8.622","article-title":"Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests","volume":"56","author":"Dawson","year":"2001","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.berh.2016.04.006_bib45","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.1780391014","article-title":"Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities","volume":"39","author":"Saag","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2016.04.006_bib46","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years","volume":"62","author":"Turesson","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2016.04.006_bib47","first-page":"33","article-title":"Cause of death in 81 autopsied patients with rheumatoid arthritis","volume":"21","author":"Suzuki","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2016.04.006_bib48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/03009740410005845","article-title":"Death rates and causes of death in patients with rheumatoid arthritis: a population-based study","volume":"33","author":"Sihvonen","year":"2004","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"10.1016\/j.berh.2016.04.006_bib49","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/rheumatology\/38.7.668","article-title":"Extra-articular rheumatoid arthritis: prevalence and mortality","volume":"38","author":"Turesson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.berh.2016.04.006_bib50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.berh.2016.04.006_bib51","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/03009740701393957","article-title":"Pulmonary involvement in patients with early rheumatoid arthritis","volume":"36","author":"Metafratzi","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.berh.2016.04.006_bib52","first-page":"21","article-title":"Rheumatoid arthritis-associated interstitial lung disease","volume":"4","author":"Solomon","year":"2012","journal-title":"Open Access Rheumatol Res Rev"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib53","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/radiol.13130187","article-title":"Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern","volume":"270","author":"Assayag","year":"2014","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib54","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/09031936.00019210","article-title":"Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome","volume":"37","author":"Tsuchiya","year":"2011","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib55","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/13993003.00357-2015","article-title":"Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease","volume":"47","author":"Solomon","year":"2016","journal-title":"Eur Respir J."},{"issue":"11","key":"10.1016\/j.berh.2016.04.006_bib56","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/art.30513","article-title":"Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients","volume":"63","author":"Marie","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib57","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10067-009-1110-6","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"28","author":"Chen","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2016.04.006_bib58","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e3182606f0b","article-title":"A\u00a0novel dermato-pulmonary syndrome associated with MDA-5 antibodies: report of 2 cases and review of the literature","volume":"91","author":"Chaisson","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.berh.2016.04.006_bib59","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1378\/chest.123.4.1096","article-title":"Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation","volume":"123","author":"Arakawa","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.berh.2016.04.006_bib60","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/RHU.0b013e3181b0e910","article-title":"Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience","volume":"15","author":"Mileti","year":"2009","journal-title":"J\u00a0Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib61","doi-asserted-by":"crossref","first-page":"e98824","DOI":"10.1371\/journal.pone.0098824","article-title":"Prognostic factors for myositis-associated interstitial lung disease","volume":"9","author":"Fujisawa","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.berh.2016.04.006_bib62","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S1806-37132011000100015","article-title":"Myositis-related interstitial lung disease and antisynthetase syndrome","volume":"37","author":"Solomon","year":"2011","journal-title":"J\u00a0Bras Pneumol Publ Of Soc Bras Pneumol Tisilogia"},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib63","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1378\/chest.08-2233","article-title":"Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature","volume":"135","author":"Kalluri","year":"2009","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib64","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"issue":"3","key":"10.1016\/j.berh.2016.04.006_bib65","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/rheumatology\/keq233","article-title":"The impact of rheumatological evaluation in the management of patients with interstitial lung disease","volume":"50","author":"Castelino","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.berh.2016.04.006_bib66","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.200204-373OC","article-title":"Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease","volume":"167","author":"Flaherty","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.berh.2016.04.006_bib67","first-page":"81","article-title":"Idiopathic pulmonary fibrosis and pulmonary fibrosis in diffuse systemic sclerosis: two fibroses with different prognoses","volume":"64","author":"Papiris","year":"1997","journal-title":"Respir Int Rev Thorac Dis"},{"issue":"1","key":"10.1016\/j.berh.2016.04.006_bib68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1378\/chest.08-2572","article-title":"Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia","volume":"136","author":"Song","year":"2009","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib69","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2559.2004.01896.x","article-title":"Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis","volume":"44","author":"Tansey","year":"2004","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.berh.2016.04.006_bib70","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/RCT.0b013e318181d551","article-title":"Computed tomographic features of idiopathic fibrosing interstitial pneumonia: comparison with pulmonary fibrosis related to collagen vascular disease","volume":"33","author":"Hwang","year":"2009","journal-title":"J\u00a0Comput Assist Tomogr"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib71","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2214\/ajr.161.2.8333359","article-title":"Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy","volume":"161","author":"Bhalla","year":"1993","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.berh.2016.04.006_bib72","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/art.24372","article-title":"Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis","volume":"61","author":"Le Goff","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2016.04.006_bib73","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.rmed.2013.05.002","article-title":"Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD)","volume":"107","author":"Solomon","year":"2013","journal-title":"Respir Med"},{"issue":"22","key":"10.1016\/j.berh.2016.04.006_bib74","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A\u00a0phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.berh.2016.04.006_bib75","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.berh.2016.04.006_bib76","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Idiopathic Pulmonary Fibrosis Clinical Research N","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.berh.2016.04.006_bib77","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201202-0314OC","article-title":"A\u00a0placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis","volume":"186","author":"Noth","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.berh.2016.04.006_bib78","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/rheumatology\/kes244","article-title":"Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis","volume":"51","author":"Mori","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.berh.2016.04.006_bib79","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archinte.1989.00390030075014","article-title":"Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration?","volume":"149","author":"Johnson","year":"1989","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.berh.2016.04.006_bib80","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semarthrit.2010.08.003","article-title":"Infectious complications in polymyositis and dermatomyositis: a series of 279 patients","volume":"41","author":"Marie","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib81","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.sult.2006.01.001","article-title":"Drug-induced lung diseases: most common reaction patterns and corresponding high-resolution CT manifestations","volume":"27","author":"Silva","year":"2006","journal-title":"Semin Ultrasound CT MR"},{"issue":"4","key":"10.1016\/j.berh.2016.04.006_bib82","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L","article-title":"Esophageal involvement and pulmonary manifestations in systemic sclerosis","volume":"45","author":"Marie","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib83","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1183\/09031936.00211311","article-title":"Silent gastro-oesophageal reflux and microaspiration in IPF: mounting evidence for anti-reflux therapy?","volume":"39","author":"Raghu","year":"2012","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.berh.2016.04.006_bib84","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.healun.2014.01.858","article-title":"Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation","volume":"33","author":"Yazdani","year":"2014","journal-title":"J\u00a0Heart Lung Transpl"},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib85","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/01.bor.0000434670.39773.a8","article-title":"Lung transplantation in patients with scleroderma","volume":"25","author":"De Cruz","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2016.04.006_bib86","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1016\/j.transproceed.2014.09.163","article-title":"Is lung transplantation a valuable therapeutic option for patients with pulmonary polymyositis? Experiences from the Leuven transplant cohort","volume":"46","author":"Ameye","year":"2014","journal-title":"Transplant Proc"},{"issue":"25","key":"10.1016\/j.berh.2016.04.006_bib87","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl. 10","key":"10.1016\/j.berh.2016.04.006_bib88","article-title":"The scleroderma lung study II (SLS II) shows that both oral cyclophosphamide (CYC) and mycophenolate mofetil (MMF) are efficacious in treating progressive interstitial lung disease (ILD) in patients with systemic sclerosis (SSc)","volume":"67","author":"Clements","year":"2015","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2016.04.006_bib89","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.semarthrit.2014.09.002","article-title":"Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis","volume":"44","author":"Bosello","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2016.04.006_bib90","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.rmed.2012.01.001","article-title":"Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome","volume":"106","author":"Marie","year":"2012","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.berh.2016.04.006_bib91","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2016.04.006_bib92","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4236\/ojra.2012.23011","article-title":"Open-label, pilot study of safety and clinical effects of rituximab in patients\u00a0with rheumatoid arthritis-associated interstitial pneumonia","volume":"2","author":"Matteson","year":"2012","journal-title":"Open J Rheumatol Autoimmune Disord"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib93","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-0034-1371528","article-title":"Pulmonary manifestations of polymyositis\/dermatomyositis","volume":"35","author":"Hallowell","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib94","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.rdc.2014.12.006","article-title":"Pulmonary complications of inflammatory myopathy","volume":"41","author":"Miller","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.berh.2016.04.006_bib95","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/08916930500124023","article-title":"Polymyositis\/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants","volume":"38","author":"Takada","year":"2005","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.berh.2016.04.006_bib96","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/rheumatology\/keu166","article-title":"The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis","volume":"54","author":"Kurita","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.berh.2016.04.006_bib97","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00408-009-9146-6","article-title":"Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis\/dermatomyositis","volume":"187","author":"Suzuki","year":"2009","journal-title":"Lung"},{"issue":"8","key":"10.1016\/j.berh.2016.04.006_bib98","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/rheumatology\/kep157","article-title":"Rituximab treatment of the anti-synthetase syndrome: a retrospective case series","volume":"48","author":"Sem","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.berh.2016.04.006_bib99","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.berh.2016.04.006_bib100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.13-1474","article-title":"Predicting survival across chronic interstitial lung disease: the ILD-GAP model","volume":"145","author":"Ryerson","year":"2014","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.berh.2016.04.006_bib101","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1378\/chest.15-0003","article-title":"Predicting mortality in systemic sclerosis-associated interstitial lung disease using risk prediction models derived from idiopathic pulmonary fibrosis","volume":"148","author":"Ryerson","year":"2015","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.berh.2016.04.006_bib102","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0034-1371527","article-title":"Biomarkers in connective tissue disease-associated interstitial lung disease","volume":"35","author":"Bonella","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.berh.2016.04.006_bib103","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/art.37881","article-title":"Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease","volume":"65","author":"Harlow","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2016.04.006_bib104","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Annals of the rheumatic diseases."},{"issue":"7","key":"10.1016\/j.berh.2016.04.006_bib105","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/art.24586","article-title":"Anti-U11\/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis","volume":"61","author":"Fertig","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2016.04.006_bib106","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3109\/s10165-012-0756-0","article-title":"Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis\/dermatomyositis","volume":"23","author":"Arai","year":"2013","journal-title":"Mod Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2016.04.006_bib107","first-page":"1112","article-title":"Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis","volume":"31","author":"Yanaba","year":"2004","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2016.04.006_bib108","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.rmed.2004.04.003","article-title":"Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT","volume":"98","author":"Kinoshita","year":"2004","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.berh.2016.04.006_bib109","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ard.59.4.257","article-title":"Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis\/dermatomyositis","volume":"59","author":"Bandoh","year":"2000","journal-title":"Ann Rheum Dis"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694216300201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694216300201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T04:36:41Z","timestamp":1718685401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694216300201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S1521694216300201"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2016.04.006","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Connective tissue disease-related interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2016.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}